Trump Addresses Possible FDA Commissioner Firing
In a recent meeting with reporters, President Donald Trump played down the speculation surrounding the potential firing of Food and Drug Administration Commissioner Marty McCulley. “I’ve been reading about it, but I don’t know anything about it,” Trump stated when asked about McCulley’s situation. He added, “No big deal” in response to further inquiries.
The rumors regarding McCulley’s possible dismissal began circulating earlier this week after the Wall Street Journal reported that Trump had urged him to fast-track the approval of nicotine e-cigarettes. According to reports, McCulley declined to comply, which reportedly upset the President.
As a result of this tension, Trump approved a plan to remove McCulley, as noted by the Journal. However, he did not confirm this on the record, and when probed about whether he would appoint a new FDA head, he responded, “No, no.”
McCulley, who was appointed as FDA Commissioner in March 2025, has faced several controversies during his tenure. Pro-life activists have accused him of stalling a safety review of the abortion drug mifepristone.
Marjorie Dannenfelser, the president of SBA Pro-Life America, voiced concerns, stating that “this is a triple crisis for the pro-life movement and for the Republican Party,” and called for McCulley’s firing. She emphasized the need for strong leadership to drive turnout among Republican voters.
On the other hand, some pharmaceutical and biotech companies have criticized McCulley as well. John Crowley, who leads the Biotechnology Innovation Organization, pointed out that recent cuts have been damaging, suggesting that a lack of strategic approach could harm the FDA’s modernization efforts.
Contrasting opinions emerged from supporters of McCulley, particularly within the Make America Healthy Again (MAHA) movement led by Robert F. Kennedy, Jr. They argue that the calls for his removal are motivated by corporate interests. Kelly Ryerson, an advocate associated with the movement, defended McCulley, stating, “Dr. McCulley is an ally of the MAHA movement.” She noted that concerns about his delay in approving flavored e-cigarettes are particularly troubling for parents.
In a post on social media, Alex Clark, affiliated with Turning Point USA, echoed a similar sentiment, asserting that McCulley prioritizes public health over corporate interests. He urged against replacing McCulley with someone aligned with pharmaceutical companies.
Bani Hari, a food activist and prominent figure in the MAHA movement, argued that firing McCulley would be a significant misstep. The ongoing debate reflects the contrasting perspectives surrounding FDA leadership and its policies.
Fox News Digital has reached out to relevant parties, including the White House, the Department of Health and Human Services, and others, for further comment.
